幽门螺旋杆菌感染对帕金森病患者运动症状及氧化应激状态的影响

Influences of Helicobacter pylori infection on motor symptoms and oxidative stress in patients with Parkinson's disease

  • 摘要: 目的 分析幽门螺旋杆菌(Helicobacter pylori,Hp)感染对帕金森病(Parkinson's disease,PD)患者运动症状及氧化应激状态的影响,为制订临床治疗方案提供参考。方法 选取2016年1-12月医院收治的PD患者85例作为病例患者,根据感染情况分为感染组71例,未感染组14例,另选取同期80名健康人作为对照组,对两组研究对象的Hp感染情况进行检测和对比;对两组研究对象的血清丙二醛(Malondialdehyde malonic dialdehyde,MDA)、还原型谷胱甘肽(Glutathione,GSH)水平进行检测和比较;对病例组患者的帕金森病症状评分量表(Unified Parkinson's disease rating scale,UPDRS)评分进行评价和比较;对合并"开关现象"病例组患者的"开""关"期时间进行记录和对比。结果 病例患者Hp感染率为83.53%高于健康人60.00%(P=0.001);对照组研究对象的血清MDA、GSH水平低于PD患者(P<0.05);感染组患者的血清MDA、GSH水平分别为(4.88±0.22)nmol/ml、(0.19±0.01)g/L 高于未感染组(4.19±0.21)nmol/ml、(0.18±0.01)g/L (P<0.05);感染患者的UPDRSⅣ评分为(3.38±0.82)分高于未感染组(2.72±0.63)分(P=0.002)。结论 PD患者具有较高的Hp感染率,Hp感染可加重患者的运动并发症程度和氧化应激状态,制订治疗方案时应酌情给予清除Hp治疗,以提高治疗效果。

     

    Abstract: OBJECTIVE To analyze the influences of Helicobacter pylori (Hp) infection on motor symptoms and oxidative stress in patients with Parkinson's disease (PD), so as to provide an objective basis for the development of effective clinical treatment. METHODS A total of 85 patients with PD from Jan. 2016 to Dec. 2016 were selected as the case group, which were divided into infection group (71 cases) and non-infection group (14 cases) according to the infection situation, and 80 healthy people were selected as the control group. The infection rate of Hp of the subjects in the two groups were detected and compared. The serum levels of malondialdehyde (MDA) and glutathione reduced (GSH) of the subjects in the two groups were detected and compared. The unified Parkinson's disease rating scale (UPDRS) score of the patients in the case group was evaluated and compared. The "open" time and the "close" time of the patients with the "open-close phenomenon " in the case group were recorded and compared. RESULTS The infection rates of Hp in the case group was 83.53%, which was significantly higher than 60.00% in the control group (P=0.001). The MDA and GSH levels of the subjects in the control group were significantly lower than those in the case group(P<0.05). The serum MDA and GSH levels of the patients with PD complicated with Hp infection were (4.88±0.22)nmol/ml and (0.19±0.01)g/L, which were significantly higher than (4.19±0.21)nmol/ml and (0.18±0.01)g/L of the patients with PD and without Hp infection (P<0.05). The UPDRSⅣ score of the patients with PD complicated with Hp infection was (3.38±0.82), which was significantly higher than (2.72±0.63) of the patients with PD and without Hp infection (P=0.002). CONCLUSION The patients with PD have higher infection rates of Hp. The Hp infection can increase the patient's degrees of motor complications and oxidative stress. The clinicians should give clearance of Hp treatment appropriately in formulating treatment plan in order to improve the therapeutic effects.

     

/

返回文章
返回